SIMEONE, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 17.991
EU - Europa 12.744
AS - Asia 4.917
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 34
SA - Sud America 29
AF - Africa 19
Totale 35.772
Nazione #
US - Stati Uniti d'America 17.907
UA - Ucraina 3.507
CN - Cina 3.102
PL - Polonia 2.552
IT - Italia 2.166
DE - Germania 1.763
HK - Hong Kong 1.091
FI - Finlandia 796
FR - Francia 671
IE - Irlanda 572
GB - Regno Unito 370
IN - India 260
VN - Vietnam 201
RU - Federazione Russa 120
SE - Svezia 93
TR - Turchia 93
CA - Canada 78
BE - Belgio 75
SG - Singapore 66
IR - Iran 60
AU - Australia 35
EU - Europa 34
BR - Brasile 19
NL - Olanda 15
ES - Italia 11
JP - Giappone 10
MU - Mauritius 9
AT - Austria 6
RO - Romania 6
KR - Corea 5
SA - Arabia Saudita 5
AR - Argentina 4
DZ - Algeria 4
JM - Giamaica 4
LA - Repubblica Popolare Democratica del Laos 4
MY - Malesia 4
BG - Bulgaria 3
IL - Israele 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
EE - Estonia 2
GR - Grecia 2
ID - Indonesia 2
MX - Messico 2
PH - Filippine 2
PT - Portogallo 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BO - Bolivia 1
CL - Cile 1
CZ - Repubblica Ceca 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
HR - Croazia 1
HU - Ungheria 1
IQ - Iraq 1
MK - Macedonia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
TN - Tunisia 1
Totale 35.772
Città #
Fairfield 2.582
Warsaw 2.546
Jacksonville 2.466
Woodbridge 1.736
Ashburn 1.548
Princeton 1.115
Hong Kong 1.089
Cambridge 1.054
Houston 1.030
Seattle 1.012
Wilmington 980
Ann Arbor 899
Nanjing 729
Chandler 619
Beijing 574
Dublin 570
Helsinki 432
New York 361
Nanchang 307
Dearborn 250
Des Moines 219
Shenyang 200
Dong Ket 196
Changsha 176
San Diego 159
Hebei 152
Milan 152
Jinan 133
Tianjin 131
Brescia 119
Jiaxing 108
Rome 97
Kunming 89
Shanghai 84
Verona 75
Brussels 69
Kocaeli 69
Toronto 65
Washington 58
Nürnberg 57
Hangzhou 55
San Mateo 55
Los Angeles 54
Ardabil 53
Zhengzhou 53
Monmouth Junction 47
Norwalk 43
London 42
Augusta 41
Lanzhou 41
Ningbo 39
San Francisco 39
Guangzhou 36
Leawood 31
Haikou 29
Lancaster 29
Bologna 26
Hefei 25
Taizhou 24
Changchun 23
Redwood City 23
Boardman 21
Fuzhou 18
Pune 18
Taiyuan 18
Napoli 17
Orange 17
Phoenix 16
Kilburn 14
Turin 14
Bari 13
Canberra 13
Frankfurt am Main 13
Modena 12
Dallas 11
Hanover 11
Melbourne 11
Padova 11
Scafati 11
Pisa 10
Torino 10
Mumbai 9
Nova Milanese 9
Prescot 9
Trieste 9
Prato 8
Tokyo 8
Vicenza 8
Gunzenhausen 7
Indiana 7
New Delhi 7
Palermo 7
Angera 6
Catania 6
Chiswick 6
Falkenstein 6
Florence 6
Genova 6
Hobart 6
Lecce 6
Totale 25.530
Nome #
Reflusso vescico ureterale nel rene trapiantato 317
INCONTINENZA URINARIA NELL'ANZIANO da Linee guida sull'incontinenza 4° Consultazione internazionale sull'incontinenza- Raccomandazioni ICI 2009 (traduzione in lingua italiana) 273
Usefulness of sacral nerve modulation in a series of multiple sclerosis patients with bladder dysfunction 255
Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: Is combination therapy better than monotherapy 252
Laparoscopic and robotic ureteral stenosis repair: a multi-institutional experience with a long-term follow-up 242
Complex Relationships between Occupation, Environment, DNA Adducts, Genetic Polymorphisms and Bladder Cancer in a Case-Control Study Using a Structural Equation Modeling. 236
CALCOLOSI MOLLE CALICEALE: UN CASO DI DIFFICILE DIAGNOSI 235
REIMPIANTO URETERALE LAPAROSCOPICO ROBOT-ASSISTED PER REFLUSSO VESCICO URETERALE RECIDIVO A INFILTRAZIONE CON MACROPLASTIQUE 231
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 230
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 200
External validation of the preoperative Karakiewicz nomogram in a large multicentre series of patients with renal cell carcinoma 187
Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma 167
Caratterizzazione dei linfonodi retroperitoneali in risonanza magnetica con mezzo di contrasto linfonodo specifico (AMI227): confronto con l'istologia 165
Robot-assisted Partial Nephrectomy and Bilateral Pyelolithotomy in Ectopic Pelvic Kidneys 165
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 160
Outcomes of Partial and Radical Nephrectomy in Octogenarians – A Multicenter International Study (Resurge) 160
The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy 151
[ProACT (Adjustable Continence Therapy) implants in case of failure of other techniques for urinary incontinence]. 150
Pros-IT CNR: an Italian prostate cancer monitoring project 146
Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years 141
Biological bases of radical prostatectomy in the management of prostate cancer patients with oligometastatic disease 140
Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration 140
How to improve patient selection for neoadjuvant chemotherapy in bladder cancer patients candidate for radical cystectomy and pelvic lymph node dissection 136
CAVECTOMIA PER INFILTRAZIONE NEOPLASTICA DA NEOPLASIA RENALE PARENCHIMALE DESTRA 135
[Acetylcholine induces human detrusor muscle cell proliferation: molecular and pharmacological characterization.] 134
DISCRIMINATION ABILITY OF THE SURFACE-INTERMEDIATE-BASE MARGIN (SIB) SCORE: AN EXTERNAL HISTOPATHOLOGICAL EVALUATION 134
Different muscarinic receptor subtypes modulate proliferation of primary human detrusor smooth muscle cells via Akt/PI3K and map kinases. 132
TERAPIA ENDOCAVITARIA DI SECONDA LINEA CON GEMCITABINA NELLA NEOPLASIA VESCICALE NON MUSCOLO INVASIVA RECIDIVA AD ALTO RISCHIO 131
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 128
Prognostic factors in a large multi-institutional series of papillary renal cell carcinoma. 127
The Simplified PADUA REnal (SPARE) nephrometry system: a novel classification of parenchymal renal tumours suitable for partial nephrectomy 127
Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: A single-center retrospective study. 126
The R.E.N.A.L. Nephrometric Nomogram Cannot Accurately Predict Malignancy or Aggressiveness of Small Renal Masses Amenable to Partial Nephrectomy. 125
Predictors of the Transition from Off to On Clamp Approach during Ongoing Robotic Partial Nephrectomy: Data from the CLOCK Randomized Clinical Trial 125
Inhibition of Survivin Is Associated with Zoledronic Acid-induced Apoptosis of Prostate Cancer Cells 124
Impact of Tumor Size on Cancer-Specific Mortality Rate after Local Tumor Ablation in T1a Renal-Cell Carcinoma 124
Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma 122
OUTCOMES OF PREVENTIVE VS DELAYED LIGATION OF DORSAL VASCULAR COMPLEX DURING RARP: PRELIMINARY RESULTS OF A RANDOMIZED TRIAL 122
Role of F18-FDG-PET/CT in restaging patients affected by renal carcinoma 121
PATHOGENESIS, FEATURES AND PROGNOSIS OF RENAL RELAPSE AFTER PARTIAL NEPHRECTOMY 120
Prediction tools in non-muscle invasive bladder cancer 120
Venous tumor thrombus consistency is not predictive of survival in patients with renal cell carcinoma: A retrospective study of 147 patients 119
Long-term Prognostic Impact of Chromosome Abnormalities in Clear Cell Renal Cell Carcinoma 119
Serum vitamin D and prostate cancer prognosis: The story continues 118
Features of Ipsilateral Renal Recurrences After Partial Nephrectomy: A Proposal of a Pathogenetic Classification 118
PATHOGENESIS, FEATURES AND PROGNOSIS OF RENAL RELAPSE AFTER PARTIAL NEPHRECTOMY 118
TRATTAMENTO CON EMBOLIZZAZIONE SUPERSELETTIVA DEL PRIAPISMO AD ALTO FLUSSO DA FISTOLA ARTERO-CAVERNOSA 117
18F-FDG PET/CT in a Patient Affected by Renal Collecting Duct (Bellini) Carcinoma 117
Comparison of Perioperative Morbidity of Radical Cystectomy with Neobladder Versus Ileal Conduit: A Matched Pair Analysis of 170 Patients 117
MP34-09 IS A DELAY IN THE TIMING OF RADICAL CYSTECTOMY REALLY DETRIMENTAL? A RETROSPECTIVE STUDY ON A SINGLE CENTRE COHORT 117
I recettori muscarinici stimolano la proliferazione di leiomiociti derivati da muscolo detrusore umano 116
PROSPECTIVE ANALYSIS OF COMPLICATIONS AND THEIR PREDICTIVE FACTORS AFTER PARTIAL NEPHRECTOMY IN A MULTICENTER COMPARATIVE ITALIAN STUDY (RECORD1) 116
External histopathological validation of the surface-intermediate-base margin score 116
[Sliding-clip robotic nephropexy]. 115
[High-intensity focused ultrasound (HIFU): our experience in the treatment of prostate cancer relapsing after radiotherapy]. 115
Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function 115
Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset 115
Reply by Authors 115
Approccio anatomo-clinico alla patologia della prostata 114
DRENAGGIO PERCUTANEO TRANSPERINEALE ECOGUIDATO DEGLI ASCESSI PROSTATICI Transperitoneal percutaneous echo-guided drainage of prostatic abscesses 114
Perioperative Outcomes of Open, Laparoscopic, and Robotic Partial Nephrectomy: A Prospective Multicenter Observational Study (The RECORd 2 Project) 114
[Ductal carcinoma of the prostate: impact on survival and therapeutic controversies of a rare tumor]. 113
LA DIFFERENZIAZIONE SARCOMATOIDE INFLUENZA NEGATIVAMENTE LA PROGNOSI NEI PAZIENTI AFFETTI DA CARCINOMA A CELLULE RENALI INDIPENDENTEMENTE DALL'ISTOTIPO 113
Surgically-induced hypertension and cardiovascular morbidity following treatment for localized kidney cancer: the impact of nephrons loss 113
Robotic versus other nephroureterectomy techniques: a systematic review and meta-analysis of over 87,000 cases 113
Renal Function Impairment Below Safety Limits Correlates With Cancer-specific Mortality in Localized Renal Cell Carcinoma: Results From a Single-center Study 111
End-Stage Renal Disease After Renal Surgery in Patients with Normal Preoperative Kidney Function: Balancing Surgical Strategy and Individual Disorders at Baseline 110
Conditional survival of patients with nonmetastatic renal cell carcinoma: How cancer-specific mortality changes after nephrectomy 110
MUSCARINIC RECEPTORS STIMULATE CELL PROLIFERATION IN THE HUMAN UROTHELIUM-DERIVED CELL LINE UROtsa 109
A prospective, multicenter evaluation of predictive factors for positive surgical margins after nephron-sparing surgery for renal cell carcinoma: The record1 italian project 109
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails 109
L'INIEZIONE PERIOSTIALE DI TEFLON NEL TRATTAMENTO DEL REFLUSSO VESCICO-URETERALE DELL'ADULTO. RISULTATI A DISTANZA 108
Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study 108
Features, risk factors and clinical outcome of "very late" recurrences after surgery for localized renal carcinoma: A retrospective evaluation of a cohort with a minimum of 10 years of follow up 108
A snapshot of nephron-sparing surgery in Italy: A prospective, multicenter report on clinical and perioperative outcomes (the RECORd 1 project) 108
Differential gene expression of cholinergic muscarinic receptor subtypes in male and female normal human urinary bladder. 107
[Insignificant prostate cancer: charateristics and predictive factors]. 106
Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: Are further improvements needed? 106
Partial Nephrectomy in Clinical T1b Renal Tumors: Multicenter Comparative Study of Open, Laparoscopic and Robot-assisted Approach (the RECORd Project) 106
VARIATIONS IN RENAL CORTEX VOLUMES BEFORE AND AFTER PARTIAL NEPHRECTOMY: A PILOT STUDY ON 30 CASES 106
Analysis of radical cystectomy and urinary diversion complications with the Clavien classification system in an Italian real life cohort. 105
TriMatch comparison of the efficacy of FloSeal versus TachoSil versus no hemostatic agents for partial nephrectomy: Results from a large multicenter dataset 105
A SNAPSHOT OF NEPHRON SPARING SURGERY IN ITALY: A PROSPECTIVE, MULTICENTER REPORT ON CLINICAL AND PERIOPERATIVE OUTCOMES (THE RECORD 1 PROJECT) 105
VENOUS TUMOR THROMBUS CONSISTENCY IS NOT PREDICTIVE OF SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA: A RETROSPECTIVE STUDY ON 147 PATIENTS 105
The occurrence of intraoperative complications during partial nephrectomy and their impact on postoperative outcome: results from the RECORd1 project 105
Riparazione di fistola vescico-rettale secondo la tecnica di york mason 104
The percentage of core involved by cancer is the best predictor of insignificant prostate cancer, according to an updated definition (tumor volume up to 2.5 cm3): analysis of a cohort of 210 consecutive patients with low-risk disease. 104
NEPHRON-SPARING SURGERY PROTECTS FROM CHRONIC KIDNEY DISEASE RELATIVE TO RADICAL NEPHRECTOMY BUT DOES NOT IMPACT ON OTHER-CAUSES MORTALITY: LONG-TERM (MORE THAN 10 YEARS) SURVIVAL AND FUNCTIONAL OUTCOMES IN PATIENTS WITH A T1A-T1B RENAL MASS 103
The Percentage of Core Involved by Cancer Is the Best Predictor of Insignificant Prostate Cancer, According to an Updated Definition (Tumor Volume up to 2.5 cm(3)): Analysis of a Cohort of 210 Consecutive Patients With Low-risk Disease 103
How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder 103
Simple enucleation is equivalent to traditional partial nephrectomy for renal cell carcinoma: results of a nonrandomized, retrospective, comparative study. 102
[Differences in morbidity of neobladder versus ileal conduit: a matched pair analysis on 134 patients] 102
Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome 101
Clinical approach to prostate disease 101
Alpha1 adrenoceptor subtypes in human urinary bladder: sex and regional comparison. 100
Predicting prostate cancer at rebiopsies in patients with high-grade prostatic intraepithelial neoplasia: a study on 546 patients. 100
[Did the staging of renal neoplasm improve with time? Retrospective study on a cohort of 2000 patients]. 99
IL RUOLO DELL'ADENOMECTOMIA RETROPUBICA SECONDO MILLIN ALLE PORTE DEL TERZO MILLENNIO 99
Adherence to the EAU guidelines on Penile Cancer Treatment: European, multicentre, retrospective study 99
A multicentre matched-pair analysis comparing robot-assisted versus open partial nephrectomy. 98
Totale 13.197
Categoria #
all - tutte 153.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.840


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.483 0 0 0 0 0 0 0 0 0 334 618 531
2019/20209.977 1.426 280 281 867 429 1.017 798 1.076 697 1.706 616 784
2020/20219.080 289 838 504 1.086 433 1.071 377 1.136 1.070 964 860 452
2021/20224.045 293 789 78 243 70 169 134 315 223 522 312 897
2022/20232.664 600 58 77 102 178 804 20 205 299 36 147 138
2023/20243.252 185 71 243 412 186 666 137 127 1.137 88 0 0
Totale 36.528